Orlistat Prices

Orlistat Prices June 2023

The price of orlistat in the United States for Q2 2023 reached 389743 USD/MT in June. Similarly, the price of orlistat in China for Q2 2023 reached 376819 USD/MT. Moreover, in Germany, the price of orlistat for Q2 2023 reached 385196 USD/MT.

Orlistat Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Orlistat Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of orlistat pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot price of orlistat at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of orlistat price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing orlistat price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Orlistat Market Analysis

The global orlistat market size reached US$ 3.4 Billion in 2023. By 2032, IMARC Group expects the market to reach US$ 5.9 Billion, at a projected CAGR of 6.20% during 2023-2032.

• Obesity rates have seen a dramatic increase globally, significantly influencing the orlistat market. According to the World Health Organization (WHO), as of 2022, 1 in 8 people worldwide were living with obesity, with adult obesity rates more than doubling since 1990 and quadrupling among children and adolescents aged 5 to 19 years. Specifically, 2.5 billion adults were overweight, and 890 million of these were classified as obese. This rapid rise in obesity has heightened public awareness of its associated health risks, including cardiovascular diseases, type 2 diabetes, and various cancers. This increased awareness is driving demand for effective weight management solutions like orlistat, which is known to help reduce the absorption of dietary fats.
• Government initiatives aimed at managing obesity are crucial drivers of the orlistat market. The World Health Organization (WHO) has been a leading force in this regard, implementing the WHO Acceleration Plan to Stop Obesity. This plan, endorsed by the 75th World Health Assembly in 2022, is designed to stimulate and support multi-sectoral action at the country level. It emphasizes scaling up proven policies and strategies to tackle the obesity epidemic globally. As of 2023, 31 governments have adopted the plan, implementing core interventions such as promoting breastfeeding, regulating food marketing to children, and integrating obesity prevention into primary health care systems.
• The shift of orlistat from a prescription-only medication to an over the counter (OTC) product in many regions has significantly expanded its market reach. This change allows individuals to access orlistat more conveniently, increasing its popularity as a weight loss aid. Pharmacies, including online platforms, have capitalized on this trend by promoting OTC orlistat products extensively. Marketing campaigns targeting weight-conscious consumers have heightened the visibility and appeal of these products. The easier accessibility and broader consumer base are key factors driving the growth of the OTC orlistat market, making it a more attractive option for those seeking immediate weight loss solutions​. According to the Consumer Healthcare Products Association, approximately 81% of adults in the U.S. use OTC medicines as a first response to minor ailments, highlighting the preference for accessible and convenient healthcare options without needing a prescription​.

Orlistat News

The report covers the latest developments, updates, and trends impacting the global orlistat market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in orlistat production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the orlistat price trend.

Latest developments in the orlistat industry:

• On May 18, 2023, Teva Pharmaceutical Industries Ltd., announced a new strategic framework with four main pillars to position the company for a new era of growth. This strategy aims to bolster the company’s strong commercial portfolio with AUSTEDO, AJOVY, UZEDYTM, and biosimilars, to amplify its innovative pipeline, sustain its generics powerhouse, and focus on the business. These four pillars are expected to deliver enhanced value and create a greater impact for patients.

Product Description

One diet drug, orlistat, is now approved to treat obesity. It works in your intestines to block the absorption of fats from the foods you eat—by acting in a much different way than the other medicines. When used in conjunction with a low-calorie diet and exercise, it's supposed to help minimize the amount of fatty food a person consumes, which can decrease body weight. Xenical, which is the prescription form, is advised for those people with overweight who also have other risk factors including, orlistat works by inhibiting pancreatic lipase, an enzyme needed by the small intestines to break down the triglycerides. Action of the lipase is inhibited, meaning the triglycerides are undigested, which otherwise would have been absorbed as free fatty acids, hence leading to decreased calorie intake and reduced absorption of fat. Clinical investigations have shown that orlistat can significantly reduce weight and improve cardiovascular risk factors when used in addition to a complete weight control program. The most common side effects are gastrointestinal problems, such as bloating and greasy stools.

Regional Coverage

The report provides a detailed analysis of the orlistat market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the orlistat price trend.

Global Orlistat Price

The report offers a holistic view of the global orlistat pricing trends in the form of orlistat price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of orlistat but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.

The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed orlistat demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Orlistat Price

European orlistat prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.

This analysis can be extended to include detailed orlistat price information for a comprehensive list of countries.

North America Orlistat Price

The analysis of orlistat prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.

Specific orlistat historical data within the United States and Canada can also be provided.

Middle East and Africa Orlistat Price

The report explores the orlistat pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on orlistat prices for countries can also be provided.

Asia Pacific Orlistat Price

The orlistat pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.

This orlistat price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Orlistat Price

The analysis of orlistat prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of orlistat pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting orlistat price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The orlistat price charts ensure our clients remain at the forefront of the industry.